Home > Name List By l > lanthanum(3+)

CAS No 587-26-8 , lanthanum(3+)

  • Name: lanthanum(3+)
  • Synonyms: Lanthanum(3 ) carbonate;tricarbonate; Foznol; Lanthanum sesquicarbonate; Dilanthanum tricarbonate;Phosbloc;lanthanum(3+); EINECS 209-599-5;
  • CAS Registry Number:
  • Density: g/cm3
  • EINECS: 209-599-5
  • Molecular Weight: 457.83764
  • InchiKey: NZPIUJUFIFZSPW-UHFFFAOYSA-H
  • InChI: InChI=1S/3CH2O3.2La/c3*2-1(3)4;;/h3*(H2,2,3,4);;/q;;;2*+3/p-6
  • Molecular Formula: C3La2O9
  • Molecular Structure:CAS No:587-26-8 lanthanum(3+)
Search by region :

Select to

587-26-8 dilanthanum tricarbonate

  • Japan Nacalai Tesque, Inc. [Manufacturers]
  • Tel: 81 75 251 1723 81-75-251-1730
  • Fax: 81-75-251-1763
  • Address: Nijo Karasuma, Nakagyo-ku Kyoto 604-0855 Japan Nakagyo-ku,KyotoJapan
Contact Supplier

587-26-8 dilanthanum tricarbonate

Contact Supplier

Select to

References of lanthanum(3+)
Title: Lanthanum Carbonate
CAS Registry Number: 587-26-8
CAS Name: Carbonic acid lanthanum(3+) salt (3:2)
Synonyms: lanthanum sesquicarbonate
Trademarks: Fosrenol (Shire); Foznol (Shire)
Molecular Formula: C3La2O9
Molecular Weight: 457.84
Percent Composition: C 7.87%, La 60.68%, O 31.45%
Line Formula: La2(CO3)3
Literature References: Binds dietary phosphate to reduce hyperphosphatemia in patients with chronic renal failure. Occurs in various hydrated forms. Prepn of hydrated forms: M. L. Salutsky, L. L. Quill, J. Am. Chem. Soc. 72, 3306 (1950); and use of hydrated pharmaceutical compositions: B. A. Murrer, N. A. Powell, US 5968976 (1999 to AnorMed Inc.). Crystal structure of octahydrate: D. B. Shinn, H. A. Eick, Inorg. Chem. 7, 1340 (1968). Soly equilibrium of octahydrate: D. Ferri, F. Salvatore, Acta Chem. Scand. 37, 531 (1983). Clinical trial in hyperphosphatemia: M. S. Joy, W. F. Finn, Am. J. Kidney Dis. 42, 96 (2003). Review of clinical development: T. S. Harrison, L. J. Scott, Drugs 64, 985-996 (2004); and clinical efficacy: F. Albaaj, A. J. Hutchison, Expert Opin. Pharmacother. 6, 319-328 (2005).
Therap-Cat: In treatment of hyperphosphatemia.
Keywords: Antihyperphosphatemic.